Trimethoprim-sulfamethoxazole — We recommend trimethoprim-sulfamethoxazole (TMP-SMX) as the treatment of choice for PCP of any severity in patients without HIV (table 1) [2].

Patients with Pneumocystis pneumonia (PCP) typically present with fever, nonproductive cough, dyspnea, and hypoxemia with diffuse bilateral ground-glass opacities on chest imaging. 1 PCP …

2020年6月29日 · PJP (previously known as Pneumocystis Carinii Pneumonia) presents differently, depending on whether the patient is HIV-negative or HIV-positive [HIV(-)PJP …

To help decide whether PCP prophylaxis for patients with autoimmune disease is indicated, clinicians can consider the number needed to treat (NNT) to prevent 1 episode of PCP …

2021年11月14日 · TMP-SMX prophylaxis significantly reduces PJP incidence with a tolerable safety profile in patients receiving rituximab treatment.

2014年12月8日 · With a focus on HIV-negative populations, this guideline outlines diagnostic approaches and provides recommendations for prophylaxis and treatment of PJP in adults and …

Pneumocystis pneumonia (PCP) is caused by Pneumocystis jirovecii, a ubiquitous fungus. The taxonomy of the organism has been changed; Pneumocystis carinii now refers only to the …

PJP is a type of life-threatening pneumonia in immunocompromised patients including those with corticosteroid treatment, hematological and solid organ malignancies, organ transplantation, …

Patients with inflammatory bowel disease (IBD) are at increased risk of developing Pneumocystis jirovecii pneumonia (PJP) than the general population. Many medications utilized for the …

The suggested approach to PJP prophylaxis in patients with glomerulonephritis is presented in this infographic. The guideline recommends prevention for patients with certain risk factors …